{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:35:41Z","timestamp":1791664541953,"version":"4.3.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00520-024-08989-z","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T03:12:01Z","timestamp":1732677121000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical pharmacist interventions on pain management in cancer patients (PharmaCAP) in low resource settings: a multicenter feasibility-pilot randomized controlled trial"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9174-7120","authenticated-orcid":false,"given":"Sunil","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simit","family":"Sapkota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew Li","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhuvan","family":"KC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibhu","family":"Paudyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun Wen Huey","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew Hua","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"key":"8989_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7\u201333","journal-title":"CA Cancer J Clin"},{"key":"8989_CR2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"8989_CR3","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1186\/s12885-022-09657-3","volume":"22","author":"B Wang","year":"2022","unstructured":"Wang B, He F, Hu Y et al (2022) Cancer incidence and mortality and risk factors in member countries of the \" Belt and Road \" initiative. BMC Cancer 22:582","journal-title":"BMC Cancer"},{"key":"8989_CR4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","volume":"8","author":"JM Kocarnik","year":"2022","unstructured":"Kocarnik JM, Compton K, Dean FE et al (2022) Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. JAMA Oncol 8:420\u2013444","journal-title":"JAMA Oncol"},{"key":"8989_CR5","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","volume":"392","author":"KJ Foreman","year":"2018","unstructured":"Foreman KJ, Marquez N, Dolgert A et al (2018) Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016\u201340 for 195 countries and territories. The Lancet 392:2052\u20132090","journal-title":"The Lancet"},{"key":"8989_CR6","unstructured":"Wild CP, Weiderpass E, Stewart BW (editors) (2020) World cancer report: cancer research for cancer prevention. Lyon (FR): International Agency for Research on Cancer."},{"key":"8989_CR7","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 74:229\u2013263","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"8989_CR8","doi-asserted-by":"crossref","first-page":"e0255499","DOI":"10.1371\/journal.pone.0255499","volume":"16","author":"G Shrestha","year":"2021","unstructured":"Shrestha G, Thakur RK, Singh R, Mulmi R, Shrestha A, Pradhan PMS (2021) Cancer burden in Nepal, 1990\u20132017: An analysis of the global burden of disease study. PLoS One 16:e0255499","journal-title":"PLoS One"},{"key":"8989_CR9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12992-015-0119-7","volume":"11","author":"SR Mishra","year":"2015","unstructured":"Mishra SR, Neupane D, Bhandari PM, Khanal V, Kallestrup P (2015) Burgeoning burden of non-communicable diseases in Nepal: a scoping review. Global Health 11:32","journal-title":"Global Health"},{"key":"8989_CR10","unstructured":"Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, Soerjomataram I, Bray F (2024) Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer. Available from: https:\/\/gco.iarc.who.int\/today. Accessed 29 Oct 2024"},{"key":"8989_CR11","unstructured":"Merskey HE (1986) Classification of chronic pain: Descriptions of chronic pain syndromes and definitions of pain terms. Pain. Supplement, 3, S1\u2013S226."},{"key":"8989_CR12","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jpainsymman.2015.12.340","volume":"51","author":"MH van den Beuken-van Everdingen","year":"2016","unstructured":"van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ (2016) Update on prevalence of pain in patients with cancer: Systematic review and meta-analysis. J Pain Symptom Manage 51(6):1070\u20131090.e9","journal-title":"J Pain Symptom Manage"},{"key":"8989_CR13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jpainsymman.2009.12.023","volume":"40","author":"K Kroenke","year":"2010","unstructured":"Kroenke K, Theobald D, Wu J, Loza JK, Carpenter JS, Tu W (2010) The association of depression and pain with health-related quality of life, disability, and health care use in cancer patients. J Pain Symptom Manage 40:327\u2013341","journal-title":"J Pain Symptom Manage"},{"key":"8989_CR14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jpainsymman.2005.04.002","volume":"30","author":"T Rust\u00f8en","year":"2005","unstructured":"Rust\u00f8en T, Moum T, Padilla G, Paul S, Miaskowski C (2005) Predictors of quality of life in oncology outpatients with pain from bone metastasis. J Pain Symptom Manage 30:234\u2013242","journal-title":"J Pain Symptom Manage"},{"key":"8989_CR15","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/cncr.25761","volume":"117","author":"CR Green","year":"2011","unstructured":"Green CR, Hart-Johnson T, Loeffler DR (2011) Cancer-related chronic pain: examining quality of life in diverse cancer survivors. Cancer 117:1994\u20132003","journal-title":"Cancer"},{"key":"8989_CR16","first-page":"211","volume":"6","author":"S O'Mahony","year":"2010","unstructured":"O\u2019Mahony S, Goulet JL, Payne R (2010) Psychosocial distress in patients treated for cancer pain: a prospective observational study. J Opioid Manag 6:211\u2013222","journal-title":"J Opioid Manag"},{"key":"8989_CR17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/pon.1431","volume":"18","author":"BJ Laird","year":"2009","unstructured":"Laird BJ, Boyd AC, Colvin LA, Fallon MT (2009) Are cancer pain and depression interdependent? A systematic review. Psychooncology 18:459\u2013464","journal-title":"Psychooncology"},{"key":"8989_CR18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0885-3924(02)00597-3","volume":"25","author":"BV Fortner","year":"2003","unstructured":"Fortner BV, Demarco G, Irving G et al (2003) Description and predictors of direct and indirect costs of pain reported by cancer patients. J Pain Symptom Manage 25:9\u201318","journal-title":"J Pain Symptom Manage"},{"key":"8989_CR19","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s11606-021-07255-w","volume":"37","author":"NB Connell","year":"2022","unstructured":"Connell NB, Prathivadi P, Lorenz KA et al (2022) Teaming in interdisciplinary chronic pain management interventions in primary care: a systematic review of randomized controlled trials. J Gen Intern Med 37:1501\u20131512","journal-title":"J Gen Intern Med"},{"key":"8989_CR20","doi-asserted-by":"crossref","first-page":"e24555","DOI":"10.2196\/24555","volume":"9","author":"L Zhang","year":"2021","unstructured":"Zhang L, McLeod HL, Liu KK et al (2021) Effect of physician-pharmacist participation in the management of ambulatory cancer pain through a digital health platform: randomized controlled trial. JMIR Mhealth Uhealth 9:e24555","journal-title":"JMIR Mhealth Uhealth"},{"key":"8989_CR21","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1177\/0300060513491170","volume":"41","author":"Y Wang","year":"2013","unstructured":"Wang Y, Huang H, Zeng Y et al (2013) Pharmacist-led medication education in cancer pain control: A multicentre randomized controlled study in Guangzhou, China. J Int Med Res 41:1462\u20131472","journal-title":"J Int Med Res"},{"issue":"60","key":"8989_CR22","first-page":"76","volume":"2020","author":"J Liu","year":"2003","unstructured":"Liu J, Wang C, Chen X et al (2003) Evaluation of pharmacist interventions as part of a multidisciplinary cancer pain management team in a Chinese academic medical center. J Am Pharm Assoc 2020(60):76\u201380","journal-title":"J Am Pharm Assoc"},{"key":"8989_CR23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.nec.2022.02.002","volume":"33","author":"MD Staudt","year":"2022","unstructured":"Staudt MD (2022) The multidisciplinary team in pain management. Neurosurg Clin N Am 33:241\u2013249","journal-title":"Neurosurg Clin N Am"},{"key":"8989_CR24","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1592\/phco.28.6.806","volume":"28","author":"JM Burke","year":"2008","unstructured":"Burke JM, Miller WA, Spencer AP et al (2008) Clinical pharmacist competencies. Pharmacotherapy 28:806\u2013815","journal-title":"Pharmacotherapy"},{"key":"8989_CR25","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jsps.2014.02.011","volume":"22","author":"J Francis","year":"2014","unstructured":"Francis J, Abraham S (2014) Clinical pharmacists: Bridging the gap between patients and physicians. Saudi Pharm J 22:600\u2013602","journal-title":"Saudi Pharm J"},{"key":"8989_CR26","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.21037\/apm-20-627","volume":"9","author":"YJ Su","year":"2020","unstructured":"Su YJ, Yan YD, Wang WJ et al (2020) Preliminary exploration on the role of clinical pharmacists in cancer pain pharmacotherapy. Ann Palliat Med 9:3070\u20133077","journal-title":"Ann Palliat Med"},{"key":"8989_CR27","doi-asserted-by":"crossref","unstructured":"Shrestha S, Kc B, Blebil AQ, Teoh SL (2022) Pharmacist involvement in cancer pain management: a systematic review and meta-Analysis. J Pain 23(7):1123\u20131142","DOI":"10.1016\/j.jpain.2022.02.002"},{"key":"8989_CR28","doi-asserted-by":"crossref","unstructured":"Shrestha S, Shakya D, Palaian S (2020) Clinical pharmacy education and practice in Nepal: a glimpse into present challenges and potential solutions. Adv Med Educ Pract 11:541\u2013548","DOI":"10.2147\/AMEP.S257351"},{"key":"8989_CR29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2147\/AMEP.S348601","volume":"13","author":"S Shrestha","year":"2022","unstructured":"Shrestha S, Shrestha S, Sapkota B, Shakya R, Roien R, Mohamed Ibrahim MI (2022) Reintroduction of post-baccalaureate doctor of pharmacy (PharmD, Post-Bac) program in nepal: exploration of the obstacles and solutions to move forward. Adv Med Educ Pract 13:159\u2013166","journal-title":"Adv Med Educ Pract"},{"key":"8989_CR30","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1177\/10781552231205025","volume":"29","author":"S Shrestha","year":"2023","unstructured":"Shrestha S, Gan SH, Paudyal V, Kc B, Sapkota S (2023) Current practices, gaps, and opportunities on the role of clinical pharmacists in cancer pain management: Perspectives from Nepal. J Oncol Pharm Pract 29:2049\u20132056","journal-title":"J Oncol Pharm Pract"},{"key":"8989_CR31","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.2147\/JPR.S360243","volume":"15","author":"P Thapa","year":"2022","unstructured":"Thapa P, Kc B, Lee SWH et al (2022) Managing pain in low resource settings: healthcare professionals\u2019 knowledge, attitude and practice regarding pain management in Western Nepal. J Pain Res 15:1587\u20131599","journal-title":"J Pain Res"},{"key":"8989_CR32","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1007\/s11136-024-03725-w","volume":"33","author":"S Shrestha","year":"2024","unstructured":"Shrestha S, Sapkota S, Teoh SL et al (2024) Comprehensive assessment of pain characteristics, quality of life, and pain management in cancer patients: a multi-center cross-sectional study. Qual Life Res 33:2755\u20132771","journal-title":"Qual Life Res"},{"key":"8989_CR33","doi-asserted-by":"crossref","first-page":"n2061","DOI":"10.1136\/bmj.n2061","volume":"374","author":"K Skivington","year":"2021","unstructured":"Skivington K, Matthews L, Simpson SA et al (2021) A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ 374:n2061","journal-title":"BMJ"},{"key":"8989_CR34","doi-asserted-by":"crossref","first-page":"a1655","DOI":"10.1136\/bmj.a1655","volume":"337","author":"P Craig","year":"2008","unstructured":"Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M (2008) Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 337:a1655","journal-title":"BMJ"},{"key":"8989_CR35","doi-asserted-by":"crossref","first-page":"e0150205","DOI":"10.1371\/journal.pone.0150205","volume":"11","author":"SM Eldridge","year":"2016","unstructured":"Eldridge SM, Lancaster GA, Campbell MJ et al (2016) Defining feasibility and pilot studies in preparation for randomised controlled trials: development of a conceptual framework. PLoS One 11:e0150205","journal-title":"PLoS One"},{"key":"8989_CR36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40814-015-0026-y","volume":"1","author":"A O\u2019Cathain","year":"2015","unstructured":"O\u2019Cathain A, Hoddinott P, Lewin S et al (2015) Maximising the impact of qualitative research in feasibility studies for randomised controlled trials: guidance for researchers. Pilot Feasibility Stud 1:32","journal-title":"Pilot Feasibility Stud"},{"key":"8989_CR37","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","volume":"340","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 340:c332","journal-title":"BMJ"},{"key":"8989_CR38","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG et al (2013) SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 158:200\u2013207","journal-title":"Ann Intern Med"},{"key":"8989_CR39","doi-asserted-by":"crossref","first-page":"e7586","DOI":"10.1136\/bmj.e7586","volume":"346","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, G\u00f8tzsche PC et al (2013) SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 346:e7586","journal-title":"BMJ"},{"key":"8989_CR40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/JMDH.S104807","volume":"9","author":"A Althubaiti","year":"2016","unstructured":"Althubaiti A (2016) Information bias in health research: definition, pitfalls, and adjustment methods. J Multidiscip Healthc 9:211\u2013217","journal-title":"J Multidiscip Healthc"},{"key":"8989_CR41","doi-asserted-by":"crossref","unstructured":"Breivik H, Borchgrevink PC, Allen SM, Rosseland LA, Romundstad L, Hals EK, Kvarstein G, Stubhaug A (2008) Assessment of pain. Br J Anaesth 101(1):17\u201324","DOI":"10.1093\/bja\/aen103"},{"key":"8989_CR42","doi-asserted-by":"crossref","unstructured":"Hartrick CT, Kovan JP, Shapiro S (2003) The numeric rating scale for clinical pain measurement: a ratio measure?. Pain practice : the official journal of World Institute of Pain, 3(4):310\u2013316","DOI":"10.1111\/j.1530-7085.2003.03034.x"},{"key":"8989_CR43","doi-asserted-by":"crossref","unstructured":"Paice JA Cohen FL (1997) Validity of a verbally administered numeric rating scale to measure cancer pain intensity. Cancer Nursing 20(2):88\u201393\u00a0","DOI":"10.1097\/00002820-199704000-00002"},{"key":"8989_CR44","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365\u2013376","journal-title":"J Natl Cancer Inst"},{"key":"8989_CR45","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jpainsymman.2010.04.020","volume":"41","author":"SM Watanabe","year":"2011","unstructured":"Watanabe SM, Nekolaichuk C, Beaumont C, Johnson L, Myers J, Strasser F (2011) A multicenter study comparing two numerical versions of the Edmonton Symptom Assessment System in palliative care patients. J Pain Symptom Manage 41:456\u2013468","journal-title":"J Pain Symptom Manage"},{"key":"8989_CR46","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/082585979100700202","volume":"7","author":"E Bruera","year":"1991","unstructured":"Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6\u20139","journal-title":"J Palliat Care"},{"key":"8989_CR47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3126\/kumj.v13i2.16783","volume":"13","author":"A Risal","year":"2015","unstructured":"Risal A, Manandhar K, Linde M, Koju R, Steiner TJ, Holen A (2015) Reliability and Validity of a Nepali-language Version of the Hospital Anxiety and Depression Scale (HADS). Kathmandu Univ Med J (KUMJ) 13:115\u2013124","journal-title":"Kathmandu Univ Med J (KUMJ)"},{"key":"8989_CR48","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/bcp.14193","volume":"86","author":"AHY Chan","year":"2020","unstructured":"Chan AHY, Horne R, Hankins M, Chisari C (2020) The medication adherence report scale: a measurement tool for eliciting patients\u2019 reports of nonadherence. Br J Clin Pharmacol 86:1281\u20131288","journal-title":"Br J Clin Pharmacol"},{"key":"8989_CR49","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0304-3959(02)00243-9","volume":"99","author":"S Gunnarsdottir","year":"2002","unstructured":"Gunnarsdottir S, Donovan HS, Serlin RC, Voge C, Ward S (2002) Patient-related barriers to pain management: the Barriers Questionnaire II (BQ-II). Pain 99:385\u2013396","journal-title":"Pain"},{"key":"8989_CR50","doi-asserted-by":"crossref","unstructured":"Shrestha S, Sapkota S, Paudyal V, Moon Z, Horne R, Gan SH (2024) Translation, cultural adaptation and validation of the medication adherence report scale (MARS-5) in nepalese cancer patients experiencing pain. J Pain Res 17:3741\u20133753","DOI":"10.2147\/JPR.S455852"},{"key":"8989_CR51","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jpainsymman.2013.10.015","volume":"48","author":"J Chen","year":"2014","unstructured":"Chen J, Lu X-y, Wang W-j et al (2014) Impact of a clinical pharmacist-led guidance team on cancer pain therapy in china: a prospective multicenter cohort study. J Pain Sympt Manage 48:500\u2013509","journal-title":"J Pain Sympt Manage"},{"key":"8989_CR52","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40545-022-00505-0","volume":"16","author":"S Shrestha","year":"2023","unstructured":"Shrestha S, Blebil AQ, Teoh SL et al (2023) Clinical pharmacists\u2019 intervention on pain management in cancer patients (PharmaCAP trial): study protocol for a randomized controlled trial. J Pharm Policy Pract 16:14","journal-title":"J Pharm Policy Pract"},{"key":"8989_CR53","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s40122-021-00342-0","volume":"11","author":"X Zheng","year":"2022","unstructured":"Zheng X, Ding H, Xu S et al (2022) Pharmacist-led management improves treatment adherence and quality of life in opioid-tolerant patients with cancer pain: a randomized controlled trial. Pain Ther 11:241\u2013252","journal-title":"Pain Ther"},{"key":"8989_CR54","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12955-017-0680-2","volume":"15","author":"U Periasamy","year":"2017","unstructured":"Periasamy U, MohdSidik S, Rampal L, Fadhilah SI, Akhtari-Zavare M, Mahmud R (2017) Effect of chemotherapy counseling by pharmacists on quality of life and psychological outcomes of oncology patients in Malaysia: a randomized control trial. Health Qual Life Outcomes 15:104","journal-title":"Health Qual Life Outcomes"},{"key":"8989_CR55","first-page":"502431","volume":"2015","author":"Y Wang","year":"2015","unstructured":"Wang Y, Wu H, Xu F (2015) Impact of clinical pharmacy services on KAP and QOL in cancer patients: a single-center experience. Biomed Res Int 2015:502431","journal-title":"Biomed Res Int"},{"key":"8989_CR56","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1200\/JCO.2001.19.23.4275","volume":"19","author":"C Miaskowski","year":"2001","unstructured":"Miaskowski C, Dodd MJ, West C et al (2001) Lack of adherence with the analgesic regimen: a significant barrier to effective cancer pain management. J Clin Oncol 19:4275\u20134279","journal-title":"J Clin Oncol"},{"key":"8989_CR57","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/bcpt.13583","volume":"129","author":"K Liu","year":"2021","unstructured":"Liu K, Huang H, Zhang L et al (2021) Effects of a physician- and pharmacist-managed clinic on pain management in cancer patients in China. Basic Clin Pharmacol Toxicol 129:36\u201343","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"8989_CR58","doi-asserted-by":"crossref","first-page":"105237","DOI":"10.1016\/j.jeconom.2021.10.014","volume":"237","author":"G Vazquez-Bare","year":"2023","unstructured":"Vazquez-Bare G (2023) Identification and estimation of spillover effects in randomized experiments. J Econ 237:105237","journal-title":"J Econ"}],"updated-by":[{"DOI":"10.1007\/s00520-025-09249-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000}}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08989-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-08989-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08989-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T02:48:29Z","timestamp":1739760509000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-08989-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["8989"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-08989-z","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]},"assertion":[{"value":"16 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00520-025-09249-4","URL":"https:\/\/doi.org\/10.1007\/s00520-025-09249-4","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received approval from the Ethical Review Board of the Nepal Health Research Council (NHRC) in Nepal and the Monash University Human Research Ethics Committee. Ethical approval was also obtained from the affiliated study site\u2019s hospital. The trial protocol was registered in the Clinical Trials Registry.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"828"}}